About
Fennec Pharmaceuticals Inc (NASDAQ:FENC) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 21 2026
Fennec Pharmaceuticals Announces Acceptance of Abstracts at the 2026 ASCO Annual Meeting
Apr 7 2026
Fennec Pharmaceuticals Announces Investigator-Sponsored Study to Be Conducted by University of Arizona Cancer Center
Mar 31 2026
Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Mar 24 2026
Fennec Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Mar 18 2026
Fennec Pharmaceuticals to Report Full Year and Fourth Quarter 2025 Financial Results on March 24, 2026
Financials
Revenue
$44.64 M
Market Cap
$221.33 M
EPS
-0.34
Google Übersetzer